DNLI

News Biogen, Denali to drop Parkinson’s therapy after mid-stage trial setback

11d ago

News Biogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised

14d ago

News Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

14d ago

News Denali's (DNLI) Candidate Selected for FDA's START Pilot Program

14d ago

News Denali Therapeutics GAAP EPS of -$0.69

25d ago

Short volume Short volume 54% of volume (3.3σ)

26d ago

News Privium Fund Opens $5.07 Million Denali Stake Ahead of FDA Drug Approval

27d ago

News Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Here's Why

56d ago

SEC filing DNLI Announces FDA Approval of AVLAYAH™ for Hunter Syndrome, 91% CSF HS Reduction, PRV Awarded

68d ago

News Denali gains on FDA approval of lead asset

69d ago

News Bristow Group Announces Closing of $500 Million Senior Secured Notes Offering and Extension of ABL Facility

126d ago

News Nicox annonce sa participation à des congrès au premier semestre 2026 et la présentation prochaine de données scientifiques

133d ago

News Denali Therapeutics Announces Board and Executive Leadership Updates

153d ago

News The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)

153d ago

News Denali Therapeutics stock holds Buy rating at Jefferies on FDA approval confidence

153d ago

News Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

155d ago